4//SEC Filing
Quinlan Paul T 4
Accession 0001062993-24-001429
CIK 0001042074other
Filed
Jan 25, 7:00 PM ET
Accepted
Jan 26, 6:28 PM ET
Size
7.1 KB
Accession
0001062993-24-001429
Insider Transaction Report
Form 4
Quinlan Paul T
General Counsel
Transactions
- Award
Common Stock
2024-01-24+28,438→ 28,438 total - Award
Employee Stock Option (right to buy)
2024-01-24+105,625→ 105,625 totalExercise: $22.85Exp: 2034-01-23→ Common Stock (105,625 underlying)
Footnotes (2)
- [F1]The grant shall vest as to 1/4 of the shares on each of January 15, 2025, January 15, 2026, January 15, 2027 and January 15, 2028.
- [F2]The option grant vests as to 1/48 of the underlying shares monthly from January 1, 2024.
Issuer
CymaBay Therapeutics, Inc.
CIK 0001042074
Entity typeother
Related Parties
1- filerCIK 0001333277
Filing Metadata
- Form type
- 4
- Filed
- Jan 25, 7:00 PM ET
- Accepted
- Jan 26, 6:28 PM ET
- Size
- 7.1 KB